Literature DB >> 9776839

Damage to yeast cells of Cryptococcus neoformans by voriconazole and fluconazole: a culture and microscopic study.

E Brummer1, K Kamei, M Miyaji.   

Abstract

A systematic cultural, cytological and microscopic study of voriconazole (VCZ) and fluconazole (FCZ) damage to Cryptococcus neoformans over time was made. When haemocytometer counts were compared with colony-forming units (cfu) viability decreased with increased drug concentration and prolonged treatment time up to 48 h. Percentage viability by vital staining correlated with cfu. Concentrations of VCZ were found to be 10-fold more potent than FCZ. At 72 h, percentage viability increased in cultures with lower drug concentrations, indicating outgrowth of surviving yeast cells. Drug treatment resulted in a cytological change in a large percentage of yeast cells characterized by a large central vacuole easily observed microscopically. Vital staining showed that there was no direct relationship between cytological changes and non-viability. These novel findings add a new approach for studying the antifungal action of VCZ and FCZ against C. neoformans and provide a new perspective on their antifungal action.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776839

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  2 in total

1.  Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.

Authors:  George R Thompson; Nathan P Wiederhold; Annette W Fothergill; Ana C Vallor; Brian L Wickes; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

2.  Time-course proteome analysis reveals the dynamic response of Cryptococcus gattii cells to fluconazole.

Authors:  Hin Siong Chong; Leona Campbell; Matthew P Padula; Cameron Hill; Elizabeth Harry; Simone S Li; Marc R Wilkins; Ben Herbert; Dee Carter
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.